Delivery Order HHSN268201200011I-HHSN26800001
- This federal contract award is to Lonza Walkersville, Inc., a foreign-owned, for-profit manufacturer of biological materials, laboratory equipment, and scientific services. The $17,154.40 firm-fixed-price contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), a civilian agency. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of specialized biomedical research products, including cell culture...
- Lonza Walkersville, Inc. received a $6,527.04 firm fixed price contract award from the National Institutes of Health (NIH) Office of the Director on November 8, 2012, for the procurement of drugs and biologicals. This contract call was placed against Lonza Walkersville's existing $10 million Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The award involved no set-aside designation, indicating open competition. The work...
- Lonza Walkersville, Inc. was awarded a Blanket Purchase Agreement (BPA) call valued at $24,766.00 by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the National Institutes of Health. This firm fixed-price contract was executed on August 29, 2016, with an ultimate completion date of October 31, 2016. The award represents a task order placed against Lonza Walkersville's existing $10 million single-award BPA with the HHS Office of Logistics and...
- Lonza Walkersville, Inc. received a $13,660 firm fixed price contract from the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health, on December 18, 2020. This award was issued as a call against the company's existing $10 million blanket purchase agreement (BPA) with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The contract was performed at the company's Walkersville, Maryland facility and...
- On December 29, 2016, the HHS Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call valued at $5,758.24 to Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment specializing in cell culture media, cell lines, and scientific instrumentation. The contract, which utilized firm fixed pricing with no set-aside designation, was performed at the awardee's Walkersville, Maryland facility and reached ultimate...
- Lonza Walkersville, Inc. was awarded a Blanket Purchase Agreement call valued at $14,995.00 by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health. The contract, awarded on August 30, 2011, with a completion date of December 31, 2011, was issued under an existing BPA using firm fixed-price terms with no set-aside designation. Performance will take place in Bethesda, Maryland. This award represents a task order call against...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc. The $3,662.36 award does not have a set-aside designation. Lonza Walkersville, a subsidiary of the global Lonza Group, is a leading provider of specialized biological materials, laboratory equipment, and scientific services to federal agencies. This contract...
- Lonza Walkersville, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $8,112 by the National Institutes of Health (NIH) Office of the Director on July 14, 2011. The contract, which was completed by December 31, 2011, utilized no set-aside designation and was performed at the contractor's facility in Walkersville, Maryland. As a supplier of biological materials and laboratory equipment, Lonza Walkersville was tasked with providing specialized products and...
- This is a $23,991.07 firm fixed-price contract awarded by the National Institutes of Health (NIH) to Lonza Walkersville, Inc., a foreign-owned for-profit manufacturer of biological materials, laboratory equipment, and scientific services. The contract was awarded as a Blanket Purchase Agreement (BPA) call, without any set-aside designation. Lonza Walkersville has a $10 million single-award BPA with the NIH Office of Logistics and Acquisition Operations, which expires on January 31, 2025. This...
- The National Institutes of Health awarded a Blanket Purchase Agreement (BPA) call valued at $3,108 to Lonza Walkersville, Inc. on August 2, 2010, with a completion date of December 31, 2010. This firm fixed-price contract, which did not utilize a set-aside designation, was funded through the NIH Service and Supply Fund (TAS 75 4554) and performed in Bethesda, Maryland. Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and scientific equipment headquartered in...
- HHSN268201200011IIndefinite Delivery Contract
- HHSN268201200011I-HHSN26800001Delivery Order
This delivery order, awarded to Lonza Walkersville, Inc. on September 18, 2012, carries a ceiling value of $713,046 and represents a firm fixed-price contract with the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health. The contract, which operated through September 16, 2017, was awarded without a set-aside designation, indicating open competition. Performance of work occurs at Lonza Walkersville's facility in Walkersville, Maryland. As a foreign-owned, for-profit manufacturer specializing in biological materials and laboratory equipment, Lonza Walkersville supplies high-precision research products including cell culture media, specialized cell lines, and advanced scientific instrumentation to federal biomedical research institutions. This delivery order falls under the larger "Gene Insertion - Pluripotent Stem Cells 2012-2017" master Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The work supports NHLBI's research initiatives, leveraging Lonza Walkersville's established capabilities as a critical supplier to multiple NIH institutes and the Food and Drug Administration. The company's expertise in cell processing devices, transfection systems, and cell culture media directly supports the institute's research needs in cardiovascular and pulmonary science, aligning with NHLBI's mission to advance heart, lung, and blood research and improve public health outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 6 | Other Administrative Action | $0 | 8/11/15 | |
| 5 | Other Administrative Action | $0 | 7/28/15 | |
| 4 | Other Administrative Action | $0 | 6/12/15 | |
| 3 | Additional Work (new agreement, FAR part 6 applies) | $298.6k | 9/19/14 | |
| 2 | Other Administrative Action | $0 | 5/20/14 |